129 related articles for article (PubMed ID: 38055636)
1. Nanointegrative In Situ Reprogramming of Tumor-Intrinsic Lipid Droplet Biogenesis for Low-Dose Radiation-Activated Ferroptosis Immunotherapy.
Zhang Q; Wang X; Zhao Y; Cheng Z; Fang D; Liu Y; Tian G; Li M; Luo Z
ACS Nano; 2023 Dec; 17(24):25419-25438. PubMed ID: 38055636
[TBL] [Abstract][Full Text] [Related]
2. An ROS-Activatable Nanoassembly Remodulates Tumor Cell Metabolism for Enhanced Ferroptosis Therapy.
Zhang Y; Li L; Li Y; Fei Y; Xue C; Yao X; Zhao Y; Wang X; Li M; Luo Z
Adv Healthc Mater; 2022 Jan; 11(2):e2101702. PubMed ID: 34710950
[TBL] [Abstract][Full Text] [Related]
3. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.
Yu J; Zhang Y; Li L; Xiang Y; Yao X; Zhao Y; Cai K; Li M; Li Z; Luo Z
Acta Biomater; 2023 Oct; 169():434-450. PubMed ID: 37516418
[TBL] [Abstract][Full Text] [Related]
4. Self-Assembled Copper-Based Nanoparticles for Glutathione Activated and Enzymatic Cascade-Enhanced Ferroptosis and Immunotherapy in Cancer Treatment.
Song WF; Zeng JY; Ji P; Han ZY; Sun YX; Zhang XZ
Small; 2023 Aug; 19(35):e2301148. PubMed ID: 37118853
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional Tumor-Targeting Carbon Dots for Tumor Microenvironment Activated Ferroptosis and Immunotherapy in Cancer Treatment.
Bao Y; Li G; Li S; Zhang H; Wu X; Yan R; Wang Z; Guo C; Jin Y
ACS Appl Mater Interfaces; 2023 Nov; ():. PubMed ID: 38015563
[TBL] [Abstract][Full Text] [Related]
6. X-ray-Induced Release of Nitric Oxide from Hafnium-Based Nanoradiosensitizers for Enhanced Radio-Immunotherapy.
Liu N; Zhu J; Zhu W; Chen L; Li M; Shen J; Chen M; Wu Y; Pan F; Deng Z; Liu Y; Yang G; Liu Z; Chen Q; Yang Y
Adv Mater; 2023 Jul; 35(29):e2302220. PubMed ID: 37178454
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications.
Zhai X; Lin Y; Zhu L; Wang Y; Zhang J; Liu J; Li L; Lu X
Cytokine Growth Factor Rev; 2024 Feb; 75():101-109. PubMed ID: 37658030
[TBL] [Abstract][Full Text] [Related]
8. Injectable microenvironment-responsive hydrogels with redox-activatable supramolecular prodrugs mediate ferroptosis-immunotherapy for postoperative tumor treatment.
Cheng Z; Xue C; Liu M; Cheng Z; Tian G; Li M; Xue R; Yao X; Zhang Y; Luo Z
Acta Biomater; 2023 Oct; 169():289-305. PubMed ID: 37544392
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-Based MRI-Guided Tumor Microenvironment Heating via the Synergistic Effect of Ferroptosis and Inhibition of TGF-β Signaling.
Zhou R; Liu Y; Wang Z; Lv J; Liao W; Shen Z; Rong X
Adv Healthc Mater; 2023 Aug; 12(21):e2300176. PubMed ID: 37093559
[TBL] [Abstract][Full Text] [Related]
10. Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence.
Luis G; Godfroid A; Nishiumi S; Cimino J; Blacher S; Maquoi E; Wery C; Collignon A; Longuespée R; Montero-Ruiz L; Dassoul I; Maloujahmoum N; Pottier C; Mazzucchelli G; Depauw E; Bellahcène A; Yoshida M; Noel A; Sounni NE
Redox Biol; 2021 Jul; 43():102006. PubMed ID: 34030117
[TBL] [Abstract][Full Text] [Related]
11. The role of lipid metabolic reprogramming in tumor microenvironment.
Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy.
Zheng Z; Su J; Bao X; Wang H; Bian C; Zhao Q; Jiang X
Front Immunol; 2023; 14():1247268. PubMed ID: 37600785
[TBL] [Abstract][Full Text] [Related]
13. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer.
Zhang Z; Lu M; Chen C; Tong X; Li Y; Yang K; Lv H; Xu J; Qin L
Theranostics; 2021; 11(7):3167-3182. PubMed ID: 33537080
[No Abstract] [Full Text] [Related]
14. CD36-mediated ferroptosis dampens intratumoral CD8
Ma X; Xiao L; Liu L; Ye L; Su P; Bi E; Wang Q; Yang M; Qian J; Yi Q
Cell Metab; 2021 May; 33(5):1001-1012.e5. PubMed ID: 33691090
[TBL] [Abstract][Full Text] [Related]
15. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
16. A nanoformulation for immunosuppression reversal and broad-spectrum self-amplifying antitumor ferroptosis-immunotherapy.
Yang Q; Liu T; Zheng H; Zhou Z; Huang Y; Jia H; Fu S; Zhang X; Zhang H; Liu Y; Chen X; Shan W
Biomaterials; 2023 Jan; 292():121936. PubMed ID: 36502663
[TBL] [Abstract][Full Text] [Related]
17. Heterostructural Nanoadjuvant CuSe/CoSe
Yang C; Wang M; Chang M; Yuan M; Zhang W; Tan J; Ding B; Ma P; Lin J
J Am Chem Soc; 2023 Apr; 145(13):7205-7217. PubMed ID: 36958054
[TBL] [Abstract][Full Text] [Related]
18. Boosting the synergism between cancer ferroptosis and immunotherapy via targeted stimuli-responsive liposomes.
Gao Z; Zhang J; Hou Y; Lu J; Liang J; Gao Y; Li B; Gao S; Zhao Y; Gao M; Chen J
Biomaterials; 2024 Mar; 305():122442. PubMed ID: 38142469
[TBL] [Abstract][Full Text] [Related]
19. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
[TBL] [Abstract][Full Text] [Related]
20. Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation.
Chin YC; Yang LX; Hsu FT; Hsu CW; Chang TW; Chen HY; Chen LY; Chia ZC; Hung CH; Su WC; Chiu YC; Huang CC; Liao MY
J Nanobiotechnology; 2022 Aug; 20(1):373. PubMed ID: 35953837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
